{
    "clinical_study": {
        "@rank": "6611", 
        "acronym": "VD-HCV", 
        "arm_group": [
            {
                "arm_group_label": "HCV patients under treatment", 
                "arm_group_type": "Experimental", 
                "description": "Fifty patients study group administered vitamin D were compared with 50 patients control group without vitamin D.\nDose of vitamin D 15,000 IU/week"
            }, 
            {
                "arm_group_label": "HCV  without Vit D", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Treatment of hepatitis C virus (HCV) infection was carried out using pegylated interferon\n      (PEG-IFN), ribavirin (RBV) and vitamin D (vit D) for 48 weeks in HCV genotypes 4a subjects.\n      The purpose of this study is to determine the effect of vitamin D on liver affection in such\n      patients."
        }, 
        "brief_title": "Long Term Vitamin D Therapy in HCV Treated Patients", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Hepatitis C", 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis, Chronic", 
                "Hepatitis C", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Fifty patients study group administered vit D were compared with 50 patients control group\n      without vit D. The results showed a significant elevation in vit D levels during the time\n      period, and significant reduction on HCV RNA from the 12th wk to reach zero level in 24th\n      wk. Interleukin 6 (IL-6), visfatin and hyaluronic acid levels were reduced significantly to\n      reach normal values. These concentrations reduction by the effect of vit D on HCV indicated\n      the reduction in inflammation, infection and liver cirrhosis and nearly amelioration HCV."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chronic HCV infection (positive HCV Ab more than 6 months)\n\n          -  Treated with pegylated interferon and ribavirin\n\n        Exclusion Criteria:\n\n          -  Coinfection with Hepatitis B or Hepatitis D or Human Immunodeficiency Virus\n\n          -  Previous non response to antiviral therapy.\n\n          -  Other causes of chronic liver diseases as schistosomiasis, Wilson disease and\n             alcoholic liver disease."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997203", 
            "org_study_id": "HCV-VD2013"
        }, 
        "intervention": {
            "arm_group_label": "HCV patients under treatment", 
            "description": "vitamin D was given to 50 patients (HCV under treatment)", 
            "intervention_name": "Vitamin D", 
            "intervention_type": "Drug", 
            "other_name": [
                "pegylated interferon", 
                "ribavirin"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "hepatitis C infection", 
            "vitamin D"
        ], 
        "lastchanged_date": "November 27, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bny swif", 
                        "country": "Egypt"
                    }, 
                    "name": "Tropical Medicine department, Bny swif university"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Medical biochemistry department, Cairo university"
                }
            }
        ], 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Long-term Vitamin D Therapy on IL-6, Visfatin and Hyaluronic Acid in Hepatitis C Virus Patients' Assessment", 
        "overall_official": [
            {
                "affiliation": "Medical biochemistry, Cairo university", 
                "last_name": "Dina Sabry", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Tropical Medicine department, bny swif university", 
                "last_name": "Mohamed M Tawfic", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Tropical Medicine department, bny swif university", 
                "last_name": "Yehia M Korriem", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Tropical Medicine department, Ain Shams university", 
                "last_name": "Nadia A Abdelkader", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Medical Biochemistry, faculty of Medicine Suez Canal University", 
                "last_name": "Amany Y Elkazaz", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Biochemistry department, faculty of Pharmacology Ghazza University.", 
                "last_name": "Mohamed Ghussin", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Egypt: Ain Shams University", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "composite measures of  Vitamin D, IL-6, Visfatin and Hyaluronic acid in Hepatitis C Virus Patients under antiviral therapy", 
            "safety_issue": "No", 
            "time_frame": "48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997203"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ain Shams University", 
            "investigator_full_name": "Dr. Nadia AbdelAaty AbdelKader", 
            "investigator_title": "Ass. prof. Tropical Medicine - Ain Shams University", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Ain Shams University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Nadia AbdelAaty AbdelKader", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013", 
        "why_stopped": "complete patients samples required"
    }
}